Literature DB >> 21613781

A case of xanthoma disseminatum with spontaneous resolution over 10 years: review of the literature on long-term follow-up.

H Y Park1, D H Cho, D H Joe, H C Kang, S J Yun.   

Abstract

Xanthoma disseminatum (XD) is a rare and potentially progressive non-Langerhans-cell histiocytosis. To date, a few cases of XD with spontaneous complete resolution have been described. The present report describes a 16-year-old girl who presented with yellow to red-brown papules and nodules on her eyelids, cheeks, axillae, back and buttocks. Indirect laryngoscopy showed multiple xanthomatous plaques on the larynx, posterior pharynx, epiglottis, and vocal cords. Additional findings were polyuria, polydipsia, and amenorrhea. Skin biopsy and electron microscopy results confirmed the diagnosis of XD. The patient was treated with fenofibrate, simvastatin, desmopressin, and sex-hormone replacement therapy. Her skin lesions began to slowly fade 6 years after disease onset, eventually resolving spontaneously and completely, but leaving an atrophic scar, frank anetoderma, and persisting diabetes insipidus. This case report together with a review of the English-language literature on the long-term follow-up of XD patients provides additional information on the natural history of this disease.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613781     DOI: 10.1159/000328137

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  [Therapy-resistant swelling of the upper eyelid in childhood].

Authors:  M Haustein; N Terai; J Pablik; L E Pillunat; F Sommer
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

2.  Cutaneous and laryngopharyngeal papules of xanthoma disseminatum successfully treated with 2-chlorodeoxyadenosine.

Authors:  Naomi F Briones; Norman D Hogikyan; Douglas R Fullen; Samuel M Silver; Thy Thy Do
Journal:  JAAD Case Rep       Date:  2018-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.